
Move over Mediterranean food. Experts say this East African diet could be key to better health
The Mediterranean diet may be a favourite among nutritionists, but a new study suggests that sticking to a diet local to a community in East Africa could be another key to good health.
The new study, which included 77 men and was published in the
journal Nature Medicine
, focused on the diet of the Chagga people, who live in northern Tanzania in the foothills of Mount Kilimanjaro.
It's rich in plants and fibres, featuring lots of whole grains, beans, and green vegetables.
Related
Want to live better in old age? Scientists advise following these eating habits
For two weeks, men living in rural areas who usually followed the traditional diet switched to a Western-style diet full of
processed foods
and salt, such as sausages, white bread, and fried chicken.
Meanwhile, town-dwelling men whose diets were more Western either switched to traditional foods for two weeks or added Mbege, a fermented banana drink with an alcohol content of 1 to 3 per cent, to their diets for a week.
The researchers then measured inflammation-related biomarkers in the men's blood, as well as changes to their gut microbiomes.
Switching from a traditional to a Western diet led to more inflammation, they found – but replacing a Western diet with traditional foods or drinking Mbege helped bring down inflammation, which is tied to health issues like heart disease, type 2 diabetes, and autoimmune diseases.
Some of these changes were still apparent a month after the experiment, the study found.
The results suggest that preserving traditional diets in sub-Saharan Africa – and adopting a similar diet for those further afield – could help reduce people's risk factors for chronic conditions linked to inflammation.
Related
Lower risk of diabetes to bone fractures: What are the benefits and drawbacks of being vegetarian?
"What people eat has a large impact on the immune and metabolic system," Dr Quirijn de Mast, the study's senior author and an associate professor at Radboud University Medical Centre in the Netherlands, told Euronews Health.
"It was quite unexpected that many of these effects really persisted," he added.
Diversity in diet
The researchers said that the benefits of the Chagga people's diet are likely due to how the key foods interact with each other, rather than any single superfood – similar to the Mediterranean diet, which emphasises fruits, vegetables, olive oil, and moderate amounts of fish and dairy.
"It's probably not one thing," de Mast said. "I think it's the entire diet".
Meanwhile, the fermentation process appears to enrich banana drink Mbege with microbes and chemical compounds that are good for the gut – but the researchers warned that the health benefits of the drink should be weighed against the alcohol content and possible contamination.
For people looking to incorporate the benefits of Mbege, de Mast recommends eating more fermented foods in general.
ADVERTISEMENT
Related
Butter linked to higher death risk while plant-based oils may boost health
Notably, the findings might not hold for diets across the East African region. There are more than 100 tribes in Tanzania, the study said, each with their own eating habits.
The researchers called for more studies on how various traditional diets across Africa affect people's health – especially because international nutrition guidelines don't always consider regional differences in food, culture, and genetics.
Timing is key. The rapid urbanisation of sub-Saharan Africa has come with dietary changes and less physical activity, and the region is now grappling with rising rates of obesity and related health problems.
"These heritage diets and their diversity really deserve more attention before they disappear, because I think we can really learn a lot," de Mast said.
ADVERTISEMENT
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Euronews
2 days ago
- Euronews
Cancer-fighting vaccine prompts immune response for some patients
A so-called cancer vaccine helped prolong the lives of some patients with pancreatic and bowel cancer, an early study has found. These types of cancer frequently reoccur, even after patients have undergone surgery and chemotherapy. The risk is higher when trace amounts of cancer remain in the body, enabling tumours to grow once again. To attack these malicious cells, scientists have been experimenting with cancer 'vaccines,' a type of immunotherapy that prompts certain immune cells to recognise and kill cancer cells. Pancreatic and bowel cancers often occur when people have mutations in the KRAS gene, which helps cancer tumours grow. Researchers say that makes them an ideal target for cancer vaccines. The new findings, published in the journal Nature Medicine, still need to be validated in larger studies. But they indicate immune-boosting treatments could be promising for certain cancer patients. The early-stage trial included just 25 people – 20 with pancreatic cancer and five with bowel cancer – who had completed standard treatments but still had signs of cancer in their blood. While other experimental cancer vaccines are personalised based on patients' specific tumour proteins, the jab used in this study was manufactured in bulk. After an average of nearly 20 months, 17 of the patients who received the vaccine had developed a strong immune response to the mutant tumour proteins. The pancreatic cancer patients lived an average of 29 months after vaccination, including more than 15 months cancer-free. Patients with the strongest immune responses also lived longer and remained cancer-free for longer than those with weaker responses. The study authors said that while there are other treatment options to target mutant KRAS proteins, the 'off-the-shelf' vaccine could help train patients' immune systems to recognise and attack these cancer cells. Dr Magnus Dillon, a clinician scientist at the Institute of Cancer Research in the United Kingdom who was not involved with the study, called the results 'extremely promising'. 'Many patients have these KRAS mutations, so an off-the-shelf vaccine could benefit lots of people – it saves the cost and time required to make a personalised vaccine,' Dillon said in a statement. However, Dillon and other independent experts emphasised that the findings will need to be validated in larger studies before researchers understand how effective they could be. 'While the results are promising and hypothesis-generating, they remain preliminary and will need to be validated in larger, randomised studies before clinical benefit can be confirmed,' Dr Khurum Khan, an oncologist in London, said in a statement. Richard Sullivan, director of the Institute of Cancer Policy at King's College London, also cautioned that the early findings could be skewed because the study looked at both pancreatic and bowel cancers, 'two widely different cancers with very different prognosis'. 'We've been here before with this sort of approach and not have it translate into tangible efficacy,' Sullivan said in a statement. The jab is now being tested in a phase 2 randomised trial.


Euronews
2 days ago
- Euronews
Blowing a conch shell: Could this ancient practice improve your sleep?
For thousands of years, yogis across India have raised a spiralled seashell to their lips, taken a deep breath, and released a resonant, echoing note. This is known as conch or shankh blowing, an ancient ritual believed to purify the environment, boost lung power, and focus the mind. But now, modern science says it might do more than connect you with tradition – it could also help you sleep better. A new study published in ERJ Open Research found that practicing shankh blowing could ease symptoms of obstructive sleep apnoea (OSA), a common but potentially dangerous sleep disorder in which blocked airways repeatedly interrupt breathing during the night. In a small study, people with moderate OSA who practiced the technique for six months every day not only slept better, but also felt more alert during the day and experienced fewer breathing interruptions at night. 'The way the shankh is blown is quite distinctive. It involves a deep inhalation followed by a forceful, sustained exhalation through tightly pursed lips," said Dr Krishna K Sharma, who led the study at the Eternal Heart Care Centre and Research Institute in Jaipur, India. That creates "strong vibrations and airflow resistance," he added, which may strengthen the throat and other muscles in the upper airway. In people with OSA, the upper airway often collapses overnight, leading to poor sleep. "The shankh's unique spiralling structure may also contribute to specific acoustic and mechanical effects that further stimulate and tone these muscles," Sharma said. In the trial, 30 people with moderate OSA were randomly assigned either shankh blowing or deep breathing exercises for at least 15 minutes per day, five days a week. Six months later, those in the conch-blowing group were 34 per cent less sleepy during the day. They also had four to five fewer apnoeas per hour on average and higher oxygen levels in their blood at night. How common is OSA and how else can it be treated? Obstructive sleep apnoea is far more common than many people realise. A 2019 study estimated that nearly one billion adults worldwide between the ages of 30 and 69 suffer from the condition. Symptoms can include frequent nighttime awakenings, pauses in breathing during sleep, unusual breathing patterns, daytime fatigue, and loud snoring. For many, the current standard treatment – a continuous positive airway pressure (CPAP) machine – works well but can be uncomfortable. That's why researchers are keen to explore non-invasive, low-cost alternatives. Some people opt for oral devices as an alternative to CPAP, especially those with mild to moderate symptoms. These mouthpieces work by keeping the airway open – often by repositioning the lower jaw or tongue – to reduce snoring and breathing interruptions. Potential shortcomings of the shankh study The study has some limitations. In a statement to Euronews Health, Dr Erika Kennington, head of research and innovation at the nonprofit Asthma + Lung UK, welcomed the findings but urged caution due to the study's small sample size. "It's too soon to say for certain that conch blowing can help people manage their obstructive sleep apnoea (OSA)," she said, adding that it is not clear exactly why blowing through the shell might help improve symptoms. More studies are needed to understand how alternative treatments might help OSA patients, Kennington said. Previous research, for example, has found that playing wind instruments and singing could have a small but noticeable effect for people with sleep disorders. However, Kennington also emphasised the importance of making treatments of all kinds available to patients. 'Supporting people to manage their lung health in ways that feel accessible to them is incredibly important," she said.


Euronews
4 days ago
- Euronews
As social prescribing gains traction, can nature, art, and sport heal?
When patients shuffle through Natalie Viaux's medical clinic in Brandenburg, a German city west of Berlin, she has no clue what their health problems are – and that's by design. Rather than checking patients' blood pressure or reviewing their medical charts, Viaux asks about their lives, challenges, and resources. Her clinic is experimenting with social prescribing, which aims to boost patients' health by 'prescribing' things far outside the medical realm, such as museum visits, sports clubs, and time spent in nature. Social connection and community support are a priority. 'It's valuable, all the modern medicine and what it does, yet with humans, some things can be rather simple,' Viaux, who is also a trained therapist, told Euronews Health. Here's how it works: Doctors flag patients grappling with social problems that may be hurting their wellbeing – loneliness, grief, relationship issues, finances, housing, employment, or anything else – and send them to 'link workers' like Viaux. Rather than treating a medical diagnosis, link workers partner with patients to create personalised plans that address the issues holding them back from good health. The idea is that by helping people get back on their feet – mentally, financially, or physically – they'll be empowered to take charge of their health, in turn reducing the burden on overstretched medical systems. 'We described it many years ago as focusing on what matters to people, rather than what the matter is with them,' said Dr Sam Everington, a UK-based physician and an early pioneer of the social prescribing movement, which has now spread to more than 30 countries worldwide. Research indicates social prescribing can help improve people's mental and physical health, reduce their visits to general practitioners, and boost their motivation and sense of meaning in life. Now, 22 health centres in eight European countries – Belgium, Croatia, Denmark, Germany, Poland, Portugal, Slovenia, and Spain – are trying social prescribing as part of a research project to identify how well this approach works to improve health for refugees and immigrants, older adults who live alone, and LGBTQ people. 'It's not about privileged persons who would like to have a yoga class,' Dr Wolfram Herrmann, who is leading the five-year project at Charité University Hospital in Berlin, told Euronews Health. 'It's really about people who have social problems, and usually also have mental problems and somatic problems,' he said. Social services v. social prescriptions Many programmes already address the so-called social determinants of health, even if they aren't labeled social prescribing. This includes everything from doctors' referrals to social or legal services, to 'food as medicine' initiatives or unconditional cash transfers for new mothers. But social prescribing introduces new ideas, like prescription pottery classes or community gardening, that go beyond traditional support services. Julia Hotz, a US journalist who chronicled social prescribing efforts across the globe for her book, 'The Connection Cure,' says the material and social aspects are two sides of the same coin. She views social prescribing as an umbrella term for any initiative to address the non-medical factors that affect our health. 'I think you need them both together,' Hotz told Euronews Health. 'A nature prescription or culture prescription is not going to do somebody much good if they're unemployed, struggling to make ends meet, or not eating healthy food'. 'If you think about Maslow's hierarchy of needs, you need those things in order to achieve these sorts of higher delights,' she added. 'But on the other hand, ethically, who are we to say' what matters most to an individual person's wellbeing. 'The most advanced social prescribing communities recognise all of that,' Hotz said. Link workers are key In some cases, link workers have helped physicians rethink what might improve patients' health. When Viaux joined the Brandenburg clinic, doctors initially gave her a list of services, including the Red Cross, a church, and migration support. But Viaux had some ideas of her own. 'She had a new brochure [that included] many more ideas we didn't even consider,' Dr Benjamin Senst told Euronews Health, such as local clubs, sports leagues, nature, and art. 'This was so eye-opening,' Senst said. It 'went beyond the well-established, basic structures of social support, to something broader [that] also addresses certain problems with disease and social diagnosis'. Having strong link workers, who are sometimes called bridge-builders or community health nurses, appears to be the key to making social prescribing programmes work. Everington ticked off a list of qualities they should have: emotionally intelligent, creative problem-solvers who go the extra mile to support and motivate people. 'A sign-poster might just say, 'the swimming pool is there,' Everington told Euronews Health. 'A social prescriber will say, 'well, actually, there's all female sessions.' Or, 'by the way, there's lots of people who are very overweight, so don't feel body-shy about going swimming.' Or, 'this time of day, the pools are actually empty''. 'It's actually [about] how you get somebody to go through the door, not just pointing them to the door,' he added. Viaux worked with one older woman, for example, who had mental health issues and obesity and used a wheelchair. While a doctor might have advised her to work out more, Viaux found her a water exercise programme after she said she wasn't comfortable attending a tai chi class due to her weight. She also helped the woman overcome bureaucratic hurdles to get a new wheelchair. Soon after, the woman began leaving her house more often and joined a local card-playing group. 'Once the ball was rolling, she took over,' said Viaux, who works with 40 to 50 patients at a time for a maximum of three months each. 'The beauty of social prescribing, for me, is that we connect [patients] to something existing,' she added. 'We use the resources that are already there, which makes it a very cost-effective approach to health'. Building the evidence base Yet while advocates say the benefits of social prescribing are clear, they cite a common challenge: proving, conclusively, that it works. It's also been hard to home in on exactly which programmes are the most effective. 'Oftentimes, people will look at that data and they'll say, 'Well, this was a small sample size, how do you demonstrate that it was the social prescription, specifically?'' Hotz said. 'I get that from a research perspective,' she added. 'But a social prescription will often have all these intangible benefits, like giving us more confidence, getting us out of the house more, [and] helping us to adopt other healthy behaviours'. Social prescribing also isn't a silver bullet solution to all of society's ills. As one research team put it, these programmes are 'not a quick fix to address problems of inequality and social exclusion in disadvantaged areas'. That's exactly what the new research project aims to explore, with nearly nearly €7 million in funding from the European Union. It will run a randomised trial that splits patients into two groups: one that gets social prescribing and one that receives standard care, so researchers can determine what impact the approach has on vulnerable groups. 'There are things which seem to make total sense and [be] very good, but in the end, they do not show positive effects,' Herrmann said. 'We would like to see if there are really positive effects,' with the goal of influencing health policy decisions across Europe. In the meantime, Everington is continuing to push for social prescribing – which the UK government committed to rolling out in primary care clinics nationwide in 2019 – to enter the global mainstream. He said his London clinic, which runs more than 100 social prescribing projects, hosts thousands of visitors per year, including national health ministers interested in replicating his model. 'We learned very early on that you cannot describe it and get people to understand it by a document,' Everington said. 'You actually have to come and taste it, smell it, feel it, and talk to people who are actually doing it'. His personal enthusiasm may be another selling point. 'We have a cure for a hell of a lot of disease and illness, and it's called social prescribing,' Everington said. 'This is the magic medicine that we've been looking for'.